Vineet R. Jindal - 25 Aug 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Chief Financial Officer
Signature
/s/ Vineet R. Jindal
Issuer symbol
OKUR
Transactions as of
25 Aug 2021
Net transactions value
+$37,176
Form type
4
Filing time
26 Aug 2021, 17:54:36 UTC
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $37,176 +5,000 $7.44 5,000 25 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.